Yahoo!   My Yahoo!   Mail  
Search   
Sign In
New User? Sign Up
Home > Investing > ITMN > Summary

InterMune Inc.
(ITMN)

15.60USD   Up0.10 (0.65%)   
At 2:30AM IST
 InterMune Inc. (NasdaqNM:ITMN) Delayed quote data 
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Last Trade: 15.60USD
Trade Time:2:30AM IST
Change:Up0.10 (0.65%)
Prev Close:15.50
Open:15.94
Bid:N/A
Ask:17.33 x 500
1y Target Est:20.45
Day's Range:15.50 - 16.05
52wk Range:10.48 - 19.12
Volume:850,326
Avg Vol (3m):748,598
Market Cap:728.04M
P/E (ttm):N/A
EPS (ttm):-2.64
Div & Yield:N/A (N/A%)
Add ITMN to Portfolio   Download Data

HEADLINES

 
•Biotech ETFs Immune To Broad Selling - Investor's Business Daily  - Tue 4:04AM
•Three Stocks The Insiders Love - Investopedia  - Fri, Feb 5
•[$$] Pericom, PetroQuest, Kulicke & Soffa Jump - The Wall Street Journal Online  - Tue, Feb 2
•Big Week For Pharma - CNBC  - Tue, Feb 2
•[video] Take Your Position: Pharma's Big Week - CNBC  - Tue, Feb 2
•Monday Options Recap - Seeking Alpha  - Tue, Feb 2
•InterMune call volume pops ahead of FDA panel - Reuters  - Tue, Feb 2
•InterMune gets March FDA review for lung drug - AP  - Mon, Feb 1
•InterMune to Participate in Pulmonary-Allergy Drugs Advisory Committee Meeting on March 9, 2010 - PR Newswire  - Mon, Feb 1
•Insider Trading Continues to Reflect Weak Recovery - Seeking Alpha  - Mon, Feb 1
•INTERMUNE INC Files SEC form 8-K, Other Events - EDGAR Online  - Sat, Jan 30
•Deathbed Stocks Revisited - Motley Fool  - Sat, Jan 30
» More Headlines for ITMN...

ANALYST

 
EPS Est (next year) (Dec-09) :-2.69
EPS Est (in 2 years) (Dec-10) :-2.31
Avg Rec (current)*:2.2
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
» Analyst Opinion» Estimates

BUSINESS SUMMARY

 
InterMune, Inc., a biotechnology company, focuses on the research, development, and commercialization of therapies in pulmonology and hepatology. It offers Actimmune for the treatment of patients with severe, malignant osteopetrosis, and chronic g...

» Full Company Profile